Abstract
Actinobacteria have proven themselves as the major producers of bioactive compounds with wide applications. In this study, 35 actinobacteria strains were isolated from soil samples collected from the Himalayan mountains region in Pakistan. The isolated strains were identified by polyphasic taxonomy and were prioritized based on biological and chemical screening to identify the strains with ability to produce inimitable metabolites. The biological screening included antimicrobial activity against Staphylococcus aureus, Micrococcus luteus, Salmonella enterica, Escherichia coli, Mycobacterium aurum, and Bacillus subtilis and anticancer activity using human cancer cell lines PC3 and A549. For chemical screening, methanolic extracts were investigated using TLC, HPLC-UV/MS. The actinobacteria strain PU-MM93 was selected for scale-up fermentation based on its unique chemical profile and cytotoxicity (50–60% growth inhibition) against PC3 and A549 cell lines. The scale-up fermentation of PU-MM93, followed by purification and structure elucidation of compounds revealed this strain as a promising producer of the cytotoxic anthracycline aranciamycin and aglycone SM-173-B along with the potent neuroprotective carboxamide oxachelin C. Other interesting metabolites produced include taurocholic acid as first report herein from microbial origin, pactamycate and cyclo(L-Pro-L-Leu). The study suggested exploring more bioactive microorganisms from the untapped Himalayan region in Pakistan, which can produce commercially significant compounds.
Similar content being viewed by others
Data Availability
Not Applicable.
References
Takahashi Y, Nakashima T (2018) Actinomycetes, an inexhaustible source of naturally occurring antibiotics. Antibiotics 7:45. https://doi.org/10.3390/antibiotics7020045
Ibrahimi M, Korichi W, Hafidi M, Lemee L, Ouhdouch Y, Marine LS (2020) Actinobacteria: screening for predation leads to the discovery of potential new drugs against multidrug-resistant bacteria. Antibiotics 9:91. https://doi.org/10.3390/antibiotics9020091
Braesel J, Lee JH, Arnould B, Murphy BT et al (2019) Diazaquinomycin biosynthetic gene clusters from marine and freshwater actinomycetes. J Nat Prod 82:937–946. https://doi.org/10.1021/acs.jnatprod.8b01028
Fatima A, Aftab U, Shaaban KA, Thorson JS, Sajid I (2019) Spore forming actinobacterial diversity of Cholistan desert Pakistan: polyphasic taxonomy, antimicrobial potential and chemical profiling. BMC Microbiol 19(49):1–17. https://doi.org/10.1186/s12866-019-1414-x
Goodfellow M, Nouioui I, Sanderson R, Xie F, Bull AT (2018) Rare taxa and dark microbial matter: novel bioactive actinobacteria abound in Atacama desert soils. Antonie Van Leeuwenhoek 111:1315–1332. https://doi.org/10.1007/s10482-018-1088-7
Mohammadipanah F, Wink J (2016) Actinobacteria from arid and desert habitats: diversity and biological activity. Front Microbiol 6:1541. https://doi.org/10.3389/fmicb.2015.01541
Liu G, Chater KF, Chandra G, Niu G, Tan H (2013) Molecular regulation of antibiotic biosynthesis in Streptomyces. Microbiol Mol Biol Rev 77(1):112–143. https://doi.org/10.1128/MMBR.00054-12
Ibeyaima A, Rana J, Dwivedi AK, Saini N, Gupta S et al (2018) Pseudonocardiaceae sp. TD-015 from the Thar desert, India: antimicrobial activity and identification of antimicrobial compounds. Curr Bioact Compd 14:112–118. https://doi.org/10.2174/1573407213666170104124315
Genilloud O (2017) Actinomycetes: still a source of novel antibiotics. Nat Prod Rep 34:1203–1232. https://doi.org/10.1039/C7NP00026J
Ziring L, Burki SJ (2020) Pakistan. In Encyclopedia Britannica 2020. https://www.britannica.com/place/Pakistan. Accessed 14 May 2020
Shaheen H, Shinwari ZK, Qureshi RA, Ullah Z (2012) Indigenous plant resources and their utilization practices in village populations of Kashmir Himalayas. Pak J Bot 44:739–745
Ahmad KS, Habib S (2014) Indigenous knowledge of some medicinal plants of Himalaya region, Dawarian village, Neelum valley, Azad Jammu and Kashmir, Pakistan. Univ J Plant Sci 2:40–47. https://doi.org/10.13189/ujps.2014.020203
Khan SM, Page S, Ahmad H, Shaheen H, Ullah Z, Ahmad M et al (2013) Medicinal flora and ethnoecological knowledge in the Naran valley, Western Himalaya, Pakistan. J Ethnobiol Ethnomed 9:4. https://doi.org/10.1186/1746-4269-9-4
Abbas M, Elshahawi SI, Wang X, Ponomareva LV, Sajid I, Shaaban K et al (2018) Puromycins B-E, naturally occurring amino-nucleosides produced by the Himalayan isolate Streptomyces sp. PU-14G. J Nat Prod 81:2560–2566. https://doi.org/10.1021/acs.jnatprod.8b00720
Wang X, Abbas M, Zhang Y, Elshahawi SI, Ponomareva LV, Cui Z et al (2019) Baraphenazines A-G, divergent fused phenazine-based metabolites from a Himalayan Streptomyces. J Nat Prod 82:1686–1693. https://doi.org/10.1021/acs.jnatprod.9b00289
Hayakawa M, Yoshida Y, Iimura Y (2004) Selective isolation of bioactive soil actinomycetes belonging to the Streptomyces violaceusniger phenotypic cluster. J Appl Microbiol 96:973–981. https://doi.org/10.1111/j.1365-2672.2004.02230.x
Küster E, Williams S (1964) Selection of media for isolation of Streptomycetes. Nature 202:928–929. https://doi.org/10.1038/202928a0
Shirling ET, Gottlieb D (1966) Methods for characterization of Streptomyces species. Int Bull Bact Nomen Toxonomy 16:313–340
Lane DJ, Stackebrandt E, Goodfellow M (1991) Nucleic acid techniques in bacterial systematics. Wiley, New York, pp 115–147
Wiegand I, Hilpert K, Hancock RE (2008) Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc 3:163. https://doi.org/10.1038/nprot.2007.521
Wang X, Shaaban KA, Elshahawi SI, Ponomareva LV, Sunkara M, Zhang Y et al (2013) Frenolicins C-G, pyranonaphthoquinones from Streptomyces sp. RM-4-15. J Nat Prod 76:1441–1447. https://doi.org/10.1021/np400231r
Shaaban KA, Elshahawi SI, Wang X, Horn J, Kharel MK, Leggas M et al (2015) Cytotoxic indolocarbazoles from Actinomadura melliaura ATCC 39691. J Nat Prod 78:1723–1729. https://doi.org/10.1021/acs.jnatprod.5b00429
Voss SR, Ponomareva LV, Dwaraka VB, Pardue KE, Baddar NWAH, Rodgers AK et al (2019) HDAC regulates transcription at the outset of Axolotl tail regeneration. Sci Rep 9:1–11. https://doi.org/10.1038/s41598-019-43230-6
Wang X, Elshahawi SI, Ponomareva LV, Ye Q, Liu Y, Copley GC et al (2019) Structure determination, functional characterization, and biosynthetic implications of nybomycin metabolites from a mining reclamation site-associated Streptomyces. J Nat Prod 12:3469–3476. https://doi.org/10.1021/acs.jnatprod.9b01015
Zhang Y, Ye Q, Ponomareva LV, Cao Y, Liu Y, Cui Z et al (2019) Total synthesis of griseusins and elucidation of the griseusin mechanism of action. Chem Sci 10:7641–7648. https://doi.org/10.1039/C9SC02289A
Wang X, Zhang Y, Ponomareva LV, Qiu Q, Woodcock R, Elshahawi SI et al (2017) Mccrearamycins A-D, geldanamycin-derived cyclopentenone macrolactams from an Eastern Kentucky abandoned coal mine. Microbe Angew Chem Int Ed 129:3040–3044. https://doi.org/10.1002/ange.201612447
Ponomareva LV, Athippozhy A, Thorson JS, Voss SR (2015) Using Ambystoma mexicanum (Mexican axolotl) embryos, chemical genetics, and microarray analysis to identify signaling pathways associated with tissue regeneration. Comp Biochem Physiol C 178:128–135. https://doi.org/10.1016/j.cbpc.2015.06.004
Davies-Bolorunduro OF, Adeleye IA, Akinleye MO, Wang PG (2019) Anticancer potential of metabolic compounds from marine actinomycetes isolated from Lagos Lagoon sediment. J Pharm 9:201–208. https://doi.org/10.1016/j.jpha.2019.03.004
Das R, Romi W, Das R, Sharma HK, Thakur D (2018) Antimicrobial potentiality of actinobacteria isolated from two microbiologically unexplored forest ecosystems of Northeast India. BMC Microbiol 18:71. https://doi.org/10.1186/s12866-018-1215-7
Bajaj BK, Sharma P (2011) An alkali-thermotolerant extracellular protease from a newly isolated Streptomyces sp. DP2. N Biotechnol 28:725–732. https://doi.org/10.1016/j.nbt.2011.01.001
Li J, Zhao GZ, Chen HH, Wang HB, Qin S, Zhu WY et al (2008) Antitumour and antimicrobial activities of endophytic streptomycetes from pharmaceutical plants in rainforest. Lett Appl Microbiol 47:574–580. https://doi.org/10.1111/j.1472-765X.2008.02470.x
Savi DC, Shaaban KA, Gos FM, Thorson JS, Glienke C, Rohr J (2019) Secondary metabolites produced by Microbacterium sp. LGMB471 with antifungal activity against the phytopathogen Phyllosticta citricarpa. Folia Microbiol 64:453–460. https://doi.org/10.1007/s12223-018-00668-x
Elshahawi SI, Shaaban KA, Kharel MK, Thorson JS (2015) A comprehensive review of glycosylated bacterial natural products. Chem Soc Rev 44:7591–7697. https://doi.org/10.1039/C4CS00426D
Krohn K (2009) Anthracycline chemistry and biology I: biological occurence and biosynthesis, synthesis and chemistry. Springer, Heidelberg
Le Sann C (2006) Maleimide spacers as versatile linkers in the synthesis of bioconjugates of anthracyclines. Nat Prod Rep 23:357–367. https://doi.org/10.1039/B600666N
Keller-Schierlein W, Sauerbier J, Vogler U, Zähner H (1970) Metabolites of microorganisms. Aranciamycin Helv Chim Acta 53:779. https://doi.org/10.1002/hlca.19700530413
Bols M, Binderup L, Hansen J, Rasmussen P (1992) Inhibition of collagenase by aranciamycin and aranciamycin derivatives. J Med Chem 35:2768–2771. https://doi.org/10.1021/jm00093a008
Khalil ZG, Raju R, Piggott AM, Salim AA, Blumenthal A, Capon RJ (2015) Aranciamycins I and J, antimycobacterial anthracyclines from an Australian marine-derived Streptomyces sp. J Nat Prod 78:949–952. https://doi.org/10.1021/acs.jnatprod.5b00095
Fujiwara A, Hoshino T, Westley JW (1985) Anthracycline antibiotics. Crit Rev Biotechnol 3:133–157. https://doi.org/10.3109/07388558509150782
Eida AA, Mahmud T (2019) The secondary metabolite pactamycin with potential for pharmaceutical applications: biosynthesis and regulation. Appl Microbiol 103:4337–4345. https://doi.org/10.1007/s00253-019-09831-x
Shaaban KA, Saunders MA, Zhang Y, Tran T, Elshahawi SI, Ponomareva LV et al (2016) Spoxazomicin D and oxachelin C, potent neuroprotective carboxamides from the Appalachian coal fire-associated isolate Streptomyces sp. RM-14-6. J Nat Prod 80:2–11. https://doi.org/10.1021/acs.jnatprod.6b00948
Prasad C (1995) Bioactive cyclic dipeptides. Peptides 16:151–164. https://doi.org/10.1016/0196-9781(94)00017-Z
Zhai Y, Shao Z, Cai M, Zheng L, Li G, Yu Z et al (2019) Cyclo (l-Pro–l-Leu) of Pseudomonas putida MCCC 1A00316 isolated from Antarctic soil: identification and characterization of activity against Meloidogyne incognita. Molecules 24:768. https://doi.org/10.3390/molecules24040768
Rhee KH (2002) Isolation and characterization of Streptomyces sp. KH-614 producing anti-VRE (vancomycin-resistant enterococci) antibiotics. J Gen Appl Microbiol 48:321–327. https://doi.org/10.2323/jgam.48.321
Yan PS, Song Y, Sakuno E, Nakajima H, Nakagawa H, Yabe K (2004) Cyclo (L-leucyl-L-prolyl) produced by Achromobacter xylosoxidans inhibits aflatoxin production by Aspergillus parasiticus. Appl Environ Microbiol 70:7466–7473. https://doi.org/10.1128/AEM.70.12.7466-7473.2004
Degrassi G, Aguilar C, Bosco M, Zahariev S, Pongor S, Venturi V (2002) Plant growth-promoting Pseudomonas putida WCS358 produces and secretes four cyclic dipeptides: cross-talk with quorum sensing bacterial sensors. Curr Microbiol 45:250–254. https://doi.org/10.1007/s00284-002-3704-y
Hanf R (2019) Methods of treatment of cholestatic diseases. Google Patents
Acknowledgements
This work was supported by Higher Education Commission (HEC) Pakistan grant (HEC-NRPU Project 2121). The work was also supported by National Institutes of Health grants R24 OD21479 (SRV, JST), R01 GM115261 (JST), the Center of Biomedical Research Excellence (COBRE) in Pharmaceutical Research and Innovation (CPRI, NIH P20 GM130456), the University of Kentucky College of Pharmacy, the University of Kentucky Markey Cancer Center and the National Center for Advancing Translational Sciences (Grant Nos. UL1TR000117, UL1TR001998). We thank the College of Pharmacy NMR Center (University of Kentucky) for NMR support.
Author information
Authors and Affiliations
Contributions
MTC, LVP and KAS performed research and analyzed data; MTC and KAS wrote the first draft of the manuscript; TL and SRV contributed to experimental design and consultation; IS supervised the strains isolation and identification; JST, KAS and IS contributed to the experimental design, project oversight and manuscript preparation. All authors read and approved the manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare the following competing financial interest: JST is a co-founder of Centrose (Madison, WI, USA).
Ethical Approval
This article does not contain any studies with human participants or animals performed by either of the authors.
Consent to Participate
Not Applicable.
Consent for Publication
Not Applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Cheema, M.T., Ponomareva, L.V., Liu, T. et al. Taxonomic and Metabolomics Profiling of Actinobacteria Strains from Himalayan Collection Sites in Pakistan. Curr Microbiol 78, 3044–3057 (2021). https://doi.org/10.1007/s00284-021-02557-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00284-021-02557-y